Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$667,783
-$19,133 QoQ
Shares Held
4,261
-5.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#769
of 1,603 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RNC CAPITAL MANAGEMENT LLC holds $281,592,319 across 11 Drug Manufacturers - General names. NVS ranks #9 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
517,240 | $66,465,340 | |
| 2 | ABBV |
AbbVie Inc.
|
236,727 | $59,569,982 | |
| 3 | JNJ |
Johnson & Johnson
|
191,013 | $48,511,571 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
356,290 | $45,013,678 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
645,383 | $37,186,968 | |
| 6 | LLY |
ELI LILLY & Co
|
13,549 | $16,251,078 | |
| 7 | AZN |
Astrazeneca PLC
|
32,535 | $6,169,286 | |
| 8 | AMGN |
Amgen Inc
|
2,755 | $997,640 |
All Filings in NVS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $667,783 | 4,261 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $686,916 | 4,497 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $633,926 | 4,598 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $568,872 | 4,436 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $499,287 | 4,126 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $409,800 | 3,676 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $344,963 | 3,545 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $423,503 | 3,682 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $391,985 | 3,682 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $354,612 | 3,666 | Shares | Sole | 2024-08-07 | |
| 2023-12-31 | $384,392 | 3,807 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $330,739 | 3,247 | Shares | Sole | 2023-12-27 | |
| 2023-06-30 | $355,808 | 3,526 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $341,044 | 3,707 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $324,686 | 3,579 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $309,664 | 4,074 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $351,222 | 4,155 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $356,791 | 4,066 | Shares | Sole | 2022-07-22 | |
| 2021-12-31 | $343,407 | 3,926 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $220,069 | 2,691 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $211,311 | 2,316 | Shares | Sole | 2021-07-20 | |
| No filing history on record for this holder in this stock. | ||||||